BMRN logo

BioMarin Pharmaceutical (BMRN) Interest Expense

Annual Interest Expense

$12.34 M
-$1.49 M-10.74%

December 31, 2024

Summary

Performance

1-Year Change

-10.74%

3-Year Change

-16.31%

5-Year Change

-42.42%

15-Year Change

-68.35%

BMRN Interest Expense Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

67.25%
BMRN annual interest expense is higher than 67.25% of companies in Healthcare sector

High & Low

All-time High

$43.66 M
BMRN annual interest expense is currently -71.74% below its historical high of $43.66 million

3-Year Low

$12.34 M
BMRN annual interest expense is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2024
BMRN previous annual earnings announcement was published on Dec 31, 2024

Next Annual Earnings Report Date

N/A
BMRN next annual earnings announcement has not yet been scheduled

OtherBMRNexpensesmetrics:

Annual Total Expenses

$2.38 B
BMRN annual total expenses is $2.38 billion

Annual Operating Expenses

$1.80 B
BMRN annual total operating expenses is $1.80 billion

Annual Cost Of Goods Sold

$580.24 M
BMRN annual cost of goods sold is $580.24 million

Annual Income Tax

$114.90 M
BMRN annual income tax is $114.90 million

Quarterly Interest Expense

$2.25 M
-$718.00 K-24.19%

December 31, 2024

Summary

Performance

3-Month Change

0%

1-Year Change

0%

3-Year Change

0%

5-Year Change

-54.07%

BMRN Quarterly Interest Expense Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

61.24%
BMRN quarterly interest expense is higher than 61.24% of companies in Healthcare sector

High & Low

All-time High

$11.22 M
BMRN quarterly interest expense is currently -79.94% below its historical high of $11.22 million

3-Year Low

$1.47 M
BMRN quarterly interest expense is currently +53.06% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Dec 31, 2024
BMRN previous earnings announcement was published on Dec 31, 2024

Next Quarterly Earnings Report Date

Apr 24, 2025
BMRN next earnings announcement is scheduled for Apr 24, 2025

OtherBMRNexpensesmetrics:

Quarterly Total Expenses

$585.91 M
BMRN quarterly total expenses is $585.91 million

Quarterly Operating Expenses

$449.77 M
BMRN quarterly total operating expenses is $449.77 million

Quarterly Cost Of Goods Sold

$136.14 M
BMRN quarterly cost of goods sold is $136.14 million

Quarterly Income Tax

$44.70 M
BMRN quarterly income tax is $44.70 million

TTM Interest Expense

$12.34 M
-$337.00 K-2.66%

December 31, 2024

Summary

Performance

3-Month Change

0%

1-Year Change

0%

3-Year Change

0%

5-Year Change

-41.02%

BMRN TTM Interest Expense Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

65.49%
BMRN TTM interest expense is higher than 65.49% of companies in Healthcare sector

High & Low

All-time High

$43.75 M
BMRN TTM interest expense is currently -71.80% below its historical high of $43.75 million

3-Year Low

$12.34 M
BMRN TTM interest expense is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Dec 31, 2024
BMRN previous earnings announcement was published on Dec 31, 2024

Next Quarterly Earnings Report Date

Apr 24, 2025
BMRN next earnings announcement is scheduled for Apr 24, 2025

OtherBMRNexpensesmetrics:

Annual Total Expenses

$2.38 B
BMRN annual total expenses is $2.38 billion

Annual Operating Expenses

$1.80 B
BMRN annual total operating expenses is $1.80 billion

TTM Cost Of Goods Sold

$580.24 M
BMRN TTM cost of goods sold is $580.24 million

TTM Income Tax

$114.90 M
BMRN TTM income tax is $114.90 million

Interest Expense Formula

Interest Expense = Carrying Value of Debt X Effective Interest Rate

BMRN Interest Expense Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-10.7%0.0%0.0%
3 y3 years-16.3%0.0%0.0%
5 y5 years-42.4%-54.1%-41.0%

BMRN Interest Expense Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-16.3%at low-51.9%+53.1%-20.9%at low
5 y5-year-55.1%at low-76.6%+53.1%-57.4%at low
alltimeall time-71.7%+84.7%-79.9%+386.0%-71.8%+255.3%

BioMarin Pharmaceutical Interest Expense History

DateAnnualQuarterlyTTM
Dec 2024
$12.34 M(-10.7%)
$2.25 M(-24.2%)
$12.34 M(-2.7%)
Sep 2024
-
$2.97 M(-17.0%)
$12.68 M(-6.0%)
Jun 2024
-
$3.57 M(+0.8%)
$13.49 M(-1.3%)
Mar 2024
-
$3.55 M(+37.1%)
$13.67 M(-1.1%)
Dec 2023
$13.82 M(+0.1%)
$2.59 M(-31.5%)
$13.82 M(+8.8%)
Sep 2023
-
$3.78 M(+0.6%)
$12.71 M(-6.6%)
Jun 2023
-
$3.75 M(+1.4%)
$13.61 M(-0.8%)
Mar 2023
-
$3.70 M(+151.9%)
$13.71 M(-0.7%)
Dec 2022
$13.81 M(-6.3%)
$1.47 M(-68.6%)
$13.81 M(-11.4%)
Sep 2022
-
$4.68 M(+21.2%)
$15.60 M(+5.5%)
Jun 2022
-
$3.86 M(+1.4%)
$14.79 M(+0.3%)
Mar 2022
-
$3.81 M(+17.0%)
$14.75 M(+0.0%)
Dec 2021
$14.74 M(-46.3%)
$3.25 M(-15.9%)
$14.74 M(+2.3%)
Sep 2021
-
$3.87 M(+1.4%)
$14.41 M(-28.4%)
Jun 2021
-
$3.82 M(+0.3%)
$20.14 M(-15.6%)
Mar 2021
-
$3.80 M(+30.3%)
$23.85 M(-11.5%)
Dec 2020
$27.48 M(+28.2%)
$2.92 M(-69.6%)
$26.96 M(-6.8%)
Sep 2020
-
$9.60 M(+27.5%)
$28.94 M(+29.9%)
Jun 2020
-
$7.53 M(+8.8%)
$22.28 M(+5.5%)
Mar 2020
-
$6.92 M(+41.2%)
$21.11 M(+0.9%)
Dec 2019
$21.43 M(-50.9%)
$4.90 M(+66.8%)
$20.92 M(-21.9%)
Sep 2019
-
$2.94 M(-53.8%)
$26.79 M(-23.4%)
Jun 2019
-
$6.36 M(-5.5%)
$34.97 M(-12.2%)
Mar 2019
-
$6.73 M(-37.5%)
$39.83 M(-8.8%)
Dec 2018
$43.66 M(+12.0%)
$10.76 M(-3.2%)
$43.66 M(-0.2%)
Sep 2018
-
$11.12 M(-0.9%)
$43.75 M(+3.2%)
Jun 2018
-
$11.22 M(+6.3%)
$42.37 M(+5.1%)
Mar 2018
-
$10.56 M(-2.7%)
$40.31 M(+3.4%)
Dec 2017
$38.98 M(+7.9%)
$10.85 M(+11.3%)
$38.98 M(+5.4%)
Sep 2017
-
$9.75 M(+6.5%)
$36.97 M(+1.6%)
Jun 2017
-
$9.15 M(-0.9%)
$36.38 M(+0.1%)
Mar 2017
-
$9.23 M(+4.4%)
$36.35 M(+0.6%)
Dec 2016
$36.13 M
$8.84 M(-3.4%)
$36.13 M(+0.9%)
DateAnnualQuarterlyTTM
Sep 2016
-
$9.15 M(+0.4%)
$35.80 M(+1.5%)
Jun 2016
-
$9.12 M(+1.1%)
$35.27 M(-0.2%)
Mar 2016
-
$9.02 M(+6.0%)
$35.33 M(+1.1%)
Dec 2015
$34.95 M(+4.9%)
$8.51 M(-1.3%)
$34.95 M(+0.4%)
Sep 2015
-
$8.62 M(-6.1%)
$34.81 M(+1.0%)
Jun 2015
-
$9.18 M(+6.3%)
$34.48 M(+2.4%)
Mar 2015
-
$8.64 M(+3.2%)
$33.68 M(+1.1%)
Dec 2014
$33.31 M(+255.5%)
$8.37 M(+1.0%)
$33.31 M(+4.7%)
Sep 2014
-
$8.29 M(-1.2%)
$31.81 M(+32.6%)
Jun 2014
-
$8.39 M(+1.5%)
$23.98 M(+48.7%)
Mar 2014
-
$8.26 M(+20.3%)
$16.13 M(+72.1%)
Dec 2013
$9.37 M(+40.3%)
$6.87 M(+1383.6%)
$9.37 M(+169.9%)
Sep 2013
-
$463.00 K(-12.8%)
$3.47 M(-28.3%)
Jun 2013
-
$531.00 K(-64.8%)
$4.85 M(-22.3%)
Mar 2013
-
$1.51 M(+55.6%)
$6.24 M(-6.6%)
Dec 2012
$6.68 M(-20.6%)
$970.00 K(-47.2%)
$6.68 M(-12.0%)
Sep 2012
-
$1.84 M(-4.6%)
$7.59 M(-4.2%)
Jun 2012
-
$1.93 M(-1.1%)
$7.92 M(-3.4%)
Mar 2012
-
$1.95 M(+3.7%)
$8.19 M(-2.6%)
Dec 2011
$8.41 M(-22.3%)
$1.88 M(-13.4%)
$8.41 M(-9.4%)
Sep 2011
-
$2.17 M(-1.5%)
$9.28 M(-8.3%)
Jun 2011
-
$2.20 M(+1.8%)
$10.12 M(-4.1%)
Mar 2011
-
$2.16 M(-21.2%)
$10.55 M(-2.5%)
Dec 2010
$10.82 M(-23.2%)
$2.75 M(-8.7%)
$10.82 M(+0.3%)
Sep 2010
-
$3.01 M(+14.2%)
$10.79 M(+1.2%)
Jun 2010
-
$2.63 M(+8.5%)
$10.66 M(-14.2%)
Mar 2010
-
$2.43 M(-10.5%)
$12.43 M(-11.8%)
Dec 2009
$14.09 M(-14.1%)
$2.71 M(-5.7%)
$14.09 M(-8.9%)
Sep 2009
-
$2.88 M(-34.6%)
$15.47 M(-7.3%)
Jun 2009
-
$4.40 M(+7.8%)
$16.69 M(+2.0%)
Mar 2009
-
$4.09 M(-0.2%)
$16.37 M(+33.3%)
Dec 2008
$16.39 M
$4.10 M(-0.2%)
$12.28 M(+50.0%)
Sep 2008
-
$4.11 M(+0.6%)
$8.19 M(+100.6%)
Jun 2008
-
$4.08 M
$4.08 M

FAQ

  • What is BioMarin Pharmaceutical annual interest expense?
  • What is the all time high annual interest expense for BioMarin Pharmaceutical?
  • What is BioMarin Pharmaceutical annual interest expense year-on-year change?
  • What is BioMarin Pharmaceutical quarterly interest expense?
  • What is the all time high quarterly interest expense for BioMarin Pharmaceutical?
  • What is BioMarin Pharmaceutical quarterly interest expense year-on-year change?
  • What is BioMarin Pharmaceutical TTM interest expense?
  • What is the all time high TTM interest expense for BioMarin Pharmaceutical?
  • What is BioMarin Pharmaceutical TTM interest expense year-on-year change?

What is BioMarin Pharmaceutical annual interest expense?

The current annual interest expense of BMRN is $12.34 M

What is the all time high annual interest expense for BioMarin Pharmaceutical?

BioMarin Pharmaceutical all-time high annual interest expense is $43.66 M

What is BioMarin Pharmaceutical annual interest expense year-on-year change?

Over the past year, BMRN annual interest expense has changed by -$1.49 M (-10.74%)

What is BioMarin Pharmaceutical quarterly interest expense?

The current quarterly interest expense of BMRN is $2.25 M

What is the all time high quarterly interest expense for BioMarin Pharmaceutical?

BioMarin Pharmaceutical all-time high quarterly interest expense is $11.22 M

What is BioMarin Pharmaceutical quarterly interest expense year-on-year change?

Over the past year, BMRN quarterly interest expense has changed by $0.00 (0.00%)

What is BioMarin Pharmaceutical TTM interest expense?

The current TTM interest expense of BMRN is $12.34 M

What is the all time high TTM interest expense for BioMarin Pharmaceutical?

BioMarin Pharmaceutical all-time high TTM interest expense is $43.75 M

What is BioMarin Pharmaceutical TTM interest expense year-on-year change?

Over the past year, BMRN TTM interest expense has changed by $0.00 (0.00%)